Cancer News and Research

Latest Cancer News and Research

fMRI reveals complexity of consciousness

Using a sophisticated imaging test to probe for higher-level cognitive functioning in severely brain-injured patients provides a window into consciousness -- but the view it presents is one that is blurred in fascinating ways, say researchers at Weill Cornell Medical College in the Feb. 25 online edition of the journal Brain.

25 Feb 2011

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

Amgen today announced the publication of results from a Phase 3 head-to-head trial that compared XGEVA to Zometa in preventing bone complications called skeletal-related events in 1,901 men with prostate cancer and bone metastases.

25 Feb 2011

Study: AEG-1 expression predicts erlotinib treatment response in patients with EGFR-mutant lung cancer

Spanish researchers have identified a gene whose expression level strongly predicts how well certain lung cancer patients will respond to treatment with the drug erlotinib.

25 Feb 2011

Longer looks: Best health policy picks from thought-provoking publications

Last week, in the largest nationwide bust of its kind ever, more than 700 federal agents fanned out from Miami to Los Angeles and rounded up 111 doctors, nurses, physical therapists and health company executives in nine cities.

25 Feb 2011

Signal files complaint against Med Biogene and Precision Therapeutics in Supreme Court

Med Biogene Inc., a Vancouver-based life sciences company, has been charged with fraud, and Pittsburgh-based Precision Therapeutics, Inc., was charged with tortious interference in an amended complaint filed today by Signal Genetics in Supreme Court for the County of New York.

25 Feb 2011

Collision of fast and slow protein-trains cause major DNA derailment

Scientists have published results that will forever change the way researchers view the interplay between gene expression, DNA replication and the prevention of DNA damage.

25 Feb 2011

Unigene accelerates UGP281 anorexigenic peptide to treat obese patients

Unigene Laboratories, Inc. announced today that the Company is accelerating the development of its lead proprietary anorexigenic peptide, UGP281.

25 Feb 2011

Zoledronic acid demonstrates anti-angiogenic effects in metastatic lung cancer

A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers have found.

25 Feb 2011

Study: When it comes to elective surgery, where you live matters

A new study finds wide regional variations in the treatment Medicare patients receive, especially regarding elective procedures.

25 Feb 2011

New rapid and inexpensive test can effectively identify never-smoking group with lung adenocarcinoma

An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.

25 Feb 2011

Stemline licenses clinically active oncology vaccine for dual targeting of tumor bulk and cancer stem cells

Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells (CSCs), today announced that it holds the license, from the University of Pittsburgh ("Pitt"), for the exclusive worldwide rights to a clinically active oncology vaccine directed to multiple defined targets on tumor bulk and CSCs.

25 Feb 2011

Genentech granted FDA hearing on Avastin for metastatic breast cancer

Genentech, a member of the Roche Group, today announced the U.S. Food and Drug Administration (FDA) has granted a hearing to allow the company the opportunity to present its views on why Avastin® (bevacizumab) should remain FDA-approved for metastatic breast cancer (mBC). The FDA has scheduled the hearing for June 28 to 29, 2011.

25 Feb 2011

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.

25 Feb 2011

BSD announces inclusion of hyperthermia and chemotherapy for high-risk sarcoma cancer patients

BSD Medical Corporation today announced the inclusion of hyperthermia and chemotherapy as a recommended cancer treatment for Stage IV sarcomas in the "Practice Guidelines in Oncology", which is issued by the National Comprehensive Cancer Network.

25 Feb 2011

BioCryst receives HHS contract to complete peramivir Phase 3 study in patients with influenza

BioCryst Pharmaceuticals, Inc. announced that it has been awarded a $55.0 million contract modification by the U.S. Department of Health & Human Services intended to fund to completion the Phase 3 development of its neuraminidase inhibitor, intravenous peramivir, for the treatment of patients hospitalized with influenza.

25 Feb 2011

Feasibility study to test scalp cooling device in breast cancer patients undergoing chemotherapy

A feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment will be conducted at Wake Forest University Baptist Medical Center. This will be part of the first significant study of the medical device in the United States.

25 Feb 2011

Students and nurses to receive Alumni Awards from Loyola University Chicago

The Loyola University Chicago Marcella Niehoff School of Nursing will honor two alumni and two students at the Third Annual Alumni Awards Brunch this Saturday at the Lake Shore campus.

25 Feb 2011

Variation in PSA levels does not predict prostate cancer, may lead to unnecessary biopsies

Researchers at Memorial Sloan-Kettering Cancer Center have found that change in PSA levels over time — known as PSA velocity — is a poor predictor of prostate cancer and may lead to many unnecessary biopsies.

25 Feb 2011

GUMC, FDA enter new partnership to improve public health

The U.S. Food and Drug Administration and Georgetown University Medical Center today announced a new partnership to stimulate innovation in regulatory science, ethics, education, and training. The partnership enhances the capabilities of both institutions to meet their common goal of improving public health.

25 Feb 2011

DMS joins with YSC to support young women diagnosed with breast cancer

Define My Style joins Young Survival Coalition in supporting young women diagnosed with breast cancer. The YSC store in the DMS Marketplace features custom handbags designed by DMS members, aged 13-19. Add a $2 donation to your purchase and DMS will donate 50% of the profit to YSC.

25 Feb 2011

Cancer News and Research

Latest Cancer News and Research

fMRI reveals complexity of consciousness

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

Study: AEG-1 expression predicts erlotinib treatment response in patients with EGFR-mutant lung cancer

Longer looks: Best health policy picks from thought-provoking publications

Signal files complaint against Med Biogene and Precision Therapeutics in Supreme Court

Collision of fast and slow protein-trains cause major DNA derailment

Unigene accelerates UGP281 anorexigenic peptide to treat obese patients

Zoledronic acid demonstrates anti-angiogenic effects in metastatic lung cancer

Study: When it comes to elective surgery, where you live matters

New rapid and inexpensive test can effectively identify never-smoking group with lung adenocarcinoma

Stemline licenses clinically active oncology vaccine for dual targeting of tumor bulk and cancer stem cells

Genentech granted FDA hearing on Avastin for metastatic breast cancer

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

BSD announces inclusion of hyperthermia and chemotherapy for high-risk sarcoma cancer patients

BioCryst receives HHS contract to complete peramivir Phase 3 study in patients with influenza

Feasibility study to test scalp cooling device in breast cancer patients undergoing chemotherapy

Students and nurses to receive Alumni Awards from Loyola University Chicago

Variation in PSA levels does not predict prostate cancer, may lead to unnecessary biopsies

GUMC, FDA enter new partnership to improve public health

DMS joins with YSC to support young women diagnosed with breast cancer

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in